Sarepta Therapeutics, Inc.
$2.27B- Market cap
- $2.38B
- Debt
- +$828.97M
- Cash
- −$939.65M
Capital structure 74% equity / 26% debt · EV / Revenue 1.03x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SRPT · current priceP/S 1.08x
$22.50Latest market snapshot
Implied fair value · at KRO's multiple
$10.8651.7% below market
20.81 SRPT revenue / share×0.52x KRO P/S=$10.86
Market $22.50Implied $10.86
KRO · current priceP/S 0.52x
$8.43Latest market snapshot
Implied fair value · at SRPT's multiple
$17.47107.2% above market
16.15 KRO revenue / share×1.08x SRPT P/S=$17.47
Market $8.43Implied $17.47